BCL2, BCL2 apoptosis regulator, 596

N. diseases: 1456; N. variants: 27
Disease: Actinic keratosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022602
Disease: Actinic keratosis
Actinic keratosis 		0.050 Biomarker disease BEFREE Outcome measures were: number of AKs, histological (thickness of stratum corneum and epithelium) and immunohistochemical parameters (p53, Bcl-2 and Bax), dermatology life quality index (DLQI), and adverse events. 30706457 2019
CUI: C0022602
Disease: Actinic keratosis
Actinic keratosis 		0.050 AlteredExpression disease BEFREE The stepwise progression of AK, with increased expression of anti-apoptotic Bcl-2, favors progression to SCC. 30222011 2018
CUI: C0022602
Disease: Actinic keratosis
Actinic keratosis 		0.050 Biomarker disease BEFREE The purpose of this study was to investigate whether the expression of apoptosis-associated molecules such as Erdr1, p53 and bcl-2 was affected by the treatment of ingenol mebutate in AK. 28370377 2017
CUI: C0022602
Disease: Actinic keratosis
Actinic keratosis 		0.050 Biomarker disease LHGDN Expression of p53, bcl-2 and growth hormone receptor in actinic keratosis, hypertrophic type. 12756585 2003
CUI: C0022602
Disease: Actinic keratosis
Actinic keratosis 		0.050 AlteredExpression disease BEFREE As bcl-2 expression has been established in basal cell carcinoma, this study was undertaken to determine whether it could be employed as a basis for distinguishing SBCC from SK. 9335236 1997